Robert Ivanhoe
Director/Board Member at Cynvec LLC
Robert Ivanhoe active positions
| Companies | Position | Start | End |
|---|---|---|---|
Cynvec LLC
 Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Director/Board Member | 2009-09-16 | - |
Career history of Robert Ivanhoe
Training of Robert Ivanhoe
| The Johns Hopkins University | Undergraduate Degree |
| American University | Graduate Degree |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Cynvec LLC
Cynvec LLC Pharmaceuticals: MajorHealth Technology Cynvec LLC develops oncolytic therapeutics for the treatment of cancer. It offers cancer treatment platform to activate the body’s own immune system to safely attack tumors and prevent or slow cancer recurrence. The firm develops CYN-101, a bioengineered Sindbis viral vector vaccine expressing the NY-ESO-1 tumor associated antigen for the treatment of late-stage ovarian cancer; and an immunotherapeutic vaccine for multiple possible cancer targets. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Robert Ivanhoe
- Experience
